Ixekizumab Improves Outcomes of Ankylosing Spondylitis
Plaque Psoriasis Treatments: BMS-986165 Promising & Adalimumab Biosimilar Demonstrates Equivalence
Zilretta Promising for Blood Glucose Levels; Plus Filgotinib Promising for RA
California Insurance Commissioner Sues AbbVie over Humira
Rheumatoid Arthritis Patients on Biologics Remain At Risk of Infection
Investigators Assess Infection Risk with RA Biologics
Study Says 1 Biosimilar Switch Is OK; Jury Still Out on Multiple Switches
EU Grants Marketing Authorization for Hyrimoz; Plus FDA Rejects New Drug Application for Buprenorphine Sublingual Spray
Phase 3 Trial Results: Blisibimod for Lupus Shows Possible Efficacy
- 1
- 2
- 3
- …
- 28
- Next Page »